ClinConnect ClinConnect Logo
Search / Trial NCT04911400

Effects of Class III Elastics on Stability of Orthopaedic Class III Correction

Launched by SYDNEY LOCAL HEALTH DISTRICT · May 27, 2021

Trial Information

Current as of November 10, 2025

Enrolling by invitation

Keywords

Class Iii Malocclusion Orthodontic Retention

ClinConnect Summary

This study checks whether adding small rubber bands (Class III elastics) to clear plastic retainers helps keep Class III jaw corrections more stable after orthodontic treatment in children and teenagers. It will compare two groups: (1) upper-lower clear plastic retainers with elastics, and (2) upper-lower clear plastic retainers without elastics. The trial is conducted in Australia (Chatswood and Sydney Dental Hospital) and plans to enroll about 42 participants who are 12 to 16 years old.

Who can join? Children and teens who have finished treatment for skeletal Class III malocclusion due to a retruded upper jaw, used Class III appliances and full braces, and who do not have other orthodontic treatment or medical conditions that affect growth. Participants will be randomly assigned to one of the two groups and followed for up to 5 years. The main outcome is the difference in overjet (how far the upper front teeth stick out over the lower) between the two groups after 5 years. Additional outcomes include whether jaw surgery is needed, changes in jaw and tooth positions on X-rays, how easy the retainers and elastics are to use, alignment stability, and gum health around the front teeth. The study is not FDA-regulated and is currently enrolling by invitation, with an estimated completion around 2027.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients that completed their orthodontic treatment for the management of their skeletal class III with upper jaw retrusion that was treated with Class III orthopaedic appliances, followed by full fixed appliances.
  • No congenital anomalies or craniofacial syndromes
  • No other orthodontic treatment
  • No medical history that effects growth
  • Exclusion Criteria:
  • Congenital anomalies or craniofacial syndromes
  • Other orthodontic treatment
  • Medical history that effects growth

About Sydney Local Health District

Sydney Local Health District (SLHD) is a leading healthcare organization dedicated to providing high-quality medical services and advancing health research in the Sydney region. As a prominent sponsor of clinical trials, SLHD focuses on innovative treatments and evidence-based practices to improve patient outcomes. With a commitment to ethical standards and patient safety, SLHD collaborates with healthcare professionals, researchers, and academic institutions to facilitate groundbreaking studies that contribute to the global medical community. Its comprehensive approach ensures that clinical trials are conducted efficiently, fostering advancements in healthcare that benefit both local and broader populations.

Locations

Chatswood, New South Wales, Australia

Surry Hills, New South Wales, Australia

Patients applied

0 patients applied

Trial Officials

Oyku Dalci, DDS, PhD

Principal Investigator

Sydney Local Health District, The University of Sydney

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials